OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Overexpression of CASP1 triggers acute promyelocytic leukemia cell pyroptosis and differentiation
Xibao Yu, Xin Liu, Xuan Liu, et al.
European Journal of Pharmacology (2023) Vol. 945, pp. 175614-175614
Closed Access | Times Cited: 7
Xibao Yu, Xin Liu, Xuan Liu, et al.
European Journal of Pharmacology (2023) Vol. 945, pp. 175614-175614
Closed Access | Times Cited: 7
Showing 7 citing articles:
Fucosylation inhibitor 6-alkynylfucose enhances the ATRA-induced differentiation effect on acute promyelocytic leukemia cells
Susumu Suzuki, Jianwei Liu, Yuri Sato, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 710, pp. 149541-149541
Closed Access | Times Cited: 3
Susumu Suzuki, Jianwei Liu, Yuri Sato, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 710, pp. 149541-149541
Closed Access | Times Cited: 3
Sesamin ameliorates nonalcoholic steatohepatitis through inhibiting hepatocyte pyroptosis in vivo and in vitro
Teng Zhang, Yong Zhou, Yan Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Teng Zhang, Yong Zhou, Yan Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential
Yu Zhang, Xiangxiang Zhou
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116667-116667
Open Access | Times Cited: 2
Yu Zhang, Xiangxiang Zhou
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116667-116667
Open Access | Times Cited: 2
Identification of PANoptosis-based signature for predicting the prognosis and immunotherapy response in AML
Lu Zhang, Yanan Yu, Guiqing Li, et al.
Heliyon (2024) Vol. 10, Iss. 22, pp. e40267-e40267
Open Access | Times Cited: 1
Lu Zhang, Yanan Yu, Guiqing Li, et al.
Heliyon (2024) Vol. 10, Iss. 22, pp. e40267-e40267
Open Access | Times Cited: 1
CASP1 is a target for combination therapy in pancreatic cancer
Xianfeng Wang, Zheng Chen, Dingrui Nie, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176175-176175
Closed Access | Times Cited: 3
Xianfeng Wang, Zheng Chen, Dingrui Nie, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176175-176175
Closed Access | Times Cited: 3
Insights Regarding the Role of Inflammasomes in Leukemia: What Do We Know?
Fabíola Silva Alves-Hanna, Juniel Assis Crespo-Neto, Glenda Menezes Nogueira, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-15
Open Access | Times Cited: 2
Fabíola Silva Alves-Hanna, Juniel Assis Crespo-Neto, Glenda Menezes Nogueira, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-15
Open Access | Times Cited: 2
Identification of a novel monocyte/macrophage-related gene signature for predicting survival and immune response in acute myeloid leukemia
Yun Zhan, Sixing Ma, Tianzhuo Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Yun Zhan, Sixing Ma, Tianzhuo Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
